PGRMC1/Sigma-2 receptor is confirmed to play key roles in the function of tumor proliferation (such as breast tumors, lung adenocarcinoma cells, and ovarian cancer) and chemoresistance (44–47). Here, PGRMC1 is linked to neoplasm.